Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism 4-1BB modulators(Tumor necrosis factor receptor superfamily member 9 modulators), BCMA modulators(B-cell maturation protein modulators), EGFR modulators(Epidermal growth factor receptor erbB1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | United States | 27 Feb 2017 |